Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
T.MAN Pharmaceutical PCLBKK:TMAN -0.88%21 Interest Coverage is 31.10 as of Mar. 2026, which is 2% below its 10-year median of 31.82. GuruFocus rates BKK:TMAN with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 687 Drug Manufacturers companies, T.MAN Pharmaceutical PCL ranks better than 60.99% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. T.MAN Pharmaceutical PCL's
Operating Income
for the
three
months ended in Mar. 2026 was ฿144 Mil. T.MAN Pharmaceutical PCL's Interest Expense for the
three
months ended in Mar. 2026 was ฿-5 Mil.
T.MAN Pharmaceutical PCL's interest coverage for the quarter that ended in Mar. 2026 was 31.10.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for T.MAN Pharmaceutical PCL's Interest Coverage or its related term are showing as below:
BKK:TMAN'
s Interest Coverage Range Over the Past 10 Years
Min: 19.86 Med: 31.82 Max: 35.36
Current: 22.61
BKK:TMAN's Interest Coverage is ranked better than 60.99% of 687
companies
in the Drug Manufacturers industry
Industry Median: 12.7
vs BKK:TMAN: 22.61
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
T.MAN Pharmaceutical PCL Interest Coverage Related Terms
T.MAN Pharmaceutical PCL Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BKK:TMAN vs ZTS, UTHR, VTRS: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, T.MAN Pharmaceutical PCL's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
T.MAN Pharmaceutical PCL Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, T.MAN Pharmaceutical PCL's Interest Coverage distribution charts can be found below:
* The bar in red indicates where T.MAN Pharmaceutical PCL's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
T.MAN Pharmaceutical PCL (BKK:TMAN) has a Interest Coverage of 31.10 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on T.MAN Pharmaceutical PCL and its competitors. This is near median its historical median of 31.82. Over the past decade, T.MAN Pharmaceutical PCL's Interest Coverage has ranged from 19.86 to 35.36. According to the industry distribution chart, T.MAN Pharmaceutical PCL ranks #268 out of 687 companies in the Drug Manufacturers industry, placing it in the top 39%.
Is T.MAN Pharmaceutical PCL's Interest Coverage too high?
T.MAN Pharmaceutical PCL's current Interest Coverage of 31.10 is near median its 10-year median of 31.82. Over the past 10 years, this metric has ranged from a low of 19.86 to a high of 35.36. The Drug Manufacturers industry median Interest Coverage is 12.70. T.MAN Pharmaceutical PCL's value of 31.10 is 144.9% above this industry median. Based on the distribution chart, T.MAN Pharmaceutical PCL ranks #268 out of 687 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, T.MAN Pharmaceutical PCL has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does T.MAN Pharmaceutical PCL's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, T.MAN Pharmaceutical PCL ranks #268 out of 687 companies for Interest Coverage. This puts T.MAN Pharmaceutical PCL in the upper half of its industry. The industry median Interest Coverage is 12.70. T.MAN Pharmaceutical PCL's value of 31.10 is 144.9% above this benchmark. Historically, T.MAN Pharmaceutical PCL's own Interest Coverage has ranged from 19.86 to 35.36 over the past decade. While the company's 10-year median is 31.82 vs. the industry median of 12.70, T.MAN Pharmaceutical PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.70, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. T.MAN Pharmaceutical PCL's current Interest Coverage of 31.10 is 144.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on T.MAN Pharmaceutical PCL and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. T.MAN Pharmaceutical PCL's current Interest Coverage is 31.10, which is near median its own 10-year median of 31.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T.MAN Pharmaceutical PCL stock overvalued right now?
T.MAN Pharmaceutical PCL (BKK:TMAN) has a current Interest Coverage of 31.10. The current Interest Coverage is 31.10, which is near median its 10-year median of 31.82 and 144.9% above the Drug Manufacturers industry median of 12.70. T.MAN Pharmaceutical PCL's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For T.MAN Pharmaceutical PCL (BKK:TMAN), the current Interest Coverage is 31.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
T.MAN Pharmaceutical PCL is engaged in purchasing, importing, manufacturing, and distributing original equipment and in manufacturing, distributing, and exporting modern medicines, traditional medicines, dietary supplements, and healthcare products for the healthcare industry. It offers products through brands such as T.Nutrition, T.Derma, Mommy&Me, TMT, Heaven Herb, and T.Pharmaceutical. The company's reportable segments are: Segment for manufactured products under own brand, which derives key revenue, Segment for manufactured products under third parties' brand, and Segment for trading products.
21GF Score
Get the complete analysis for BKK:TMAN
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:TMAN has been successfully added to your 
